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Amain role for interleukin-4 (IL-4) is in humoral immu-
nity, and follicular helper CD4+ T (Tfh) cells may be an
intrinsic IL-4 source. Here we demonstrate that con-
served noncoding sequence 2 (CNS2) is an essential
enhancer element for IL-4 expression in Tfh cells but
not in Th2 cells. Mice with a CNS2 deletion had
a reduction in IgG1 and IgE production and in IL-4
expression in Tfh cells. Tracking of CNS2 activity
via a GFP reporter mouse demonstrated that CNS2-
active cells expressed several markers of Tfh cells:
CXCR5, PD-1, and ICOS; the transcriptional master
regulator Bcl6; and the cytokines IL-21 and IL-4.
These CNS2-active cells were mainly localized in B
cell follicles and germinal centers. The GFP+ Tfh cells
were derived from GFP naive T cells after in vivo
systemic immunization. These results indicate that
CNS2 is an essential enhancer element required for
IL-4 expression in Tfh cells controlling humoral
immunity.
INTRODUCTION
On antigen stimulation, naive CD4+ T cells can differentiate into
Th1, Th2, or Th17 effector cells, which rapidly produce interferon
gamma (IFN-g), IL-4, or IL-17, respectively (Amsen et al., 2009;
Murphy and Reiner, 2002; Zhu et al., 2010). IL-4 was originally
identified as B cell-stimulating factor (Paul and Ohara, 1987)
and is responsible for class switch recombination to IgG1 and
IgE through the induction of germline g1 and ε transcripts (Berton
et al., 1989; Esser and Radbruch, 1989; Rothman et al., 1988),
and IgE is strongly implicated in atopic and allergic disease.
Th2 cells are the main source of IL-4, and Tfh cells may be an
alternative IL-4 source to regulate humoral immune responses188 Immunity 36, 188–200, February 24, 2012 ª2012 Elsevier Inc.(Crotty, 2011; King, 2009). Tfh cells also produce several other
cytokines (IL-21, IFN-g, or IL-17) (Crotty, 2011; King, 2009), indi-
cating that Tfh cells have a regulatory machinery distinct from
other Th cells for cytokine expression. However, the regulation
of cytokine gene expression in Tfh cells remains a mystery
because of the limited availability of ex vivo induction systems
or in vivo tracking systems to follow Tfh cell-specific cytokine
expression.
Th cell lineages have been classically defined by their func-
tional specialization, transcription factor expression, and cyto-
kine expression profile. Based on this paradigm, Tfh cells are
defined as cells that help clear viral and bacterial infections
through their ability to develop humoral immunity, express the
transcription factor Bcl-6, and secrete IL-4 and IL-21. Tfh cells
are associated with regulation of B cell function including class
switch recombination, somatic hypermutation, and affinity matu-
ration. Tfh cells are also distinguishable from other Th cells by
their location in the B cell follicles, by their expression of costimu-
latory molecules (CD40L, PD-1, and ICOS); and by a distinctive
expression of chemokine receptors; upregulation of CXCR5;
and downregulation of CCR7. The most striking difference
between Tfh and Th2 cells is in the expression of GATA3, which
is a master regulator of Th2 cell differentiation, and the produc-
tion of GATA3-dependent cytokines IL-5 and IL-13. Previous
reports proposed that IL-4 expression in Tfh cells is GATA3 inde-
pendent (Yusuf et al., 2010). However, it remains unclear how Tfh
cells can express IL-4 independently of GATA3.
Under physiological conditions, cell type specificity of gene
expression is tightly regulated by the binding accessibility of
the core transcriptional machinery and trans-acting factors to
proximal promoters and distal cis-regulatory elements. Many
of these elements have been identified experimentally by the
detection of DNaseI hypersensitive (HS) sites, accessibility of
trans-acting factors, histone code association with modification
of chromatin structure, and evolutionary conservation of
sequence identity across mammalian species (Bell et al., 2011;
Workman and Kingston, 1998). With these approaches,
a number of cis-regulatory regions have been identified in Il4,
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(Ansel et al., 2006;Wei et al., 2009;Wilson et al., 2009). We previ-
ously identified an Il4 intronic enhancer, HS2, marked by Th2
cell-specific DNaseI hypersensitivity sites, and its deletion re-
sulted in marked impairment of GATA3-mediated Il4 gene
expression in Th2 cells (Tanaka et al., 2011).
Previous reports described some interesting features of
another 30 distal enhancer, conserved noncording sequence 2
(CNS2), including its constitutive accessibility in Th2 cells (Agar-
wal and Rao, 1998), and demethylated DNA status in naive
T cells, which is maintained upon Th2 cell differentiation but
rapidly disappears in Th1 cells (Tanaka et al., 2011). Therefore,
we and others initially expected CNS2 to be a critical enhancer
for IL-4 production in Th2 cells. CD4+ T cells from mice lacking
CNS2 (also called HS5) and the 30 enhancer marked by HS5a
have a reduction in their ability to secrete Th2 cell-type cytokines
(Solymar et al., 2002); however, IL-4 production is not abolished
completely in Th2 cells (Solymar et al., 2002; Tanaka et al., 2011).
This observation was supported by the studies of IL-4 regulatory
elements in transgenic GFP reporter mice controlled by CNS2,
which marked cell type-specific sites for CD4+ T cells of memory
phenotype (MP), thymocyte-selected CD4+ (T-CD4) T cells that
develop from thymocytes selected on other MHC class
II-expressing thymocytes, and innate type of IL-4-producing
cells, such as NKT cells, mast cells, and basophils, but not Th2
cells (Sofi et al., 2011; Tanaka et al., 2006; Yagi et al., 2007).
MP T cells are similar to NKT cells (Tanaka et al., 2006) in that
they produce Th1 and Th2 cell-type cytokines after activation,
but surprisingly, IL-4 expression in these GFP+ T cell lineages
required a SAP signal but not IL-4-Stat6 signaling (Li et al.,
2007; Tanaka et al., 2006). CNS2 contains multiple putative
binding sites for recombination signal binding protein-J
(RBP-J), a critical regulator for Notch signaling (Tanaka et al.,
2006), and T cell-specific conditional deletion of RBP-J resulted
in a reduction in IgG1 and IgE because of an abrogation of the
initial IL-4 production byGFP+ cells (Tanaka et al., 2006; Tanigaki
et al., 2004).
Peyer’s patches (PP) are unique lymphoid structures
composed of several B cell follicles separated by areas contain-
ing T cells and DCs. In PP, most B cells are continually activated
by commensal bacteria, and the activated lymphocytes are
localized in GCs. GCs are special microenvironments that allow
continuous interaction between follicular B and Tfh cells through
costimulatorymolecules and cytokines and facilitate B cell prolif-
eration and subsequent class-switch recombination, somatic
hypermutation, and affinity maturation (Yu and Vinuesa, 2010).
A characteristic feature of B cells in PP GCs is class switching
from IgM to not only all IgG isotypes but also IgA, and the IgA
class switch is a preferential event in both a T cell-dependent
and -independent manner (Fagarasan, 2008). In this process,
Foxp3+ Treg cell-derived Tfh cells preferentially help IgA gener-
ation (Tsuji et al., 2009). Therefore, we reasoned that the PP
would be a useful lymphoid organ to analyze the molecular basis
of cytokine regulation in Tfh cells.
Here we demonstrate that CNS2 in the Il4 locus is a critical
element that regulates Il4 expression in Tfh cells. Deletion of
CNS2 markedly impaired IgG1 and IgE class switching but not
Th2 cell differentiation. A reporter mouse in which GFP was
controlled by the CNS2 enhancer demonstrated that CNS2-active CD4+ T cells had a phenotype similar to Tfh cells.
CNS2-active CD4+ T cells mainly localized in PP in nonimmu-
nized mice and were induced by antigen stimulation from naive
CD4+ T cells. CNS2-deficient Tfh cells showed a marked reduc-
tion in Il4 expression. Therefore, our findings indicate that CNS2
is an essential cis-acting element required for Il4 gene regulation
in Tfh cells.
RESULTS
CNS2 Enhancer Regulates IgG1 and IgE Responses
We have established a series of mutant mice lacking each HS
site in the Il4-Il13 locus (Figure S1 available online) and demon-
strated that HS2 is critical for regulating GATA3-mediated Il4
transcription. As shown previously, when naive CD4+ T cells
were stimulated under Th2 cell-polarizing conditions, HS2-defi-
cient CD4+ T cells had markedly impaired IL-4 production;
however, deletion of other elements, including CNS2, resulted
in only a slight reduction. Although the deletion in CNS2-deficient
mice included the whole CNS2 region and the last half of HS5a,
this mutant still allowed generation of Th2 type IL-4-producing
cells that coexpressed GATA3 under Th2 cell polarizing condi-
tions (Figure 1A), indicating that naive T cells can differentiate
toward Th2 cells in the absence of CNS2. We next examined
basal serum IgG1 antibody titers. Deletion of either HS2 or
CNS2 resulted in a remarkable reduction in IgG1, resembling
the titers observed in IL-4-deficient mice (Figure 1B). However,
deletion of other regulatory elements, including CGRE (Il13 distal
promoter), CNS1, 30 UTR, and HS4, had no effect on basal IgG1
titers (Figure 1B and data not shown). These results indicate that
HS2 is a common IL-4 regulator in Th2 cell responses and in
basal IgG1 production, whereas CNS2 has a profound impact
on basal IgG1 production. We found a similar reduction of
OVA-specific IgG1 in CNS2-deficient mice after systemic immu-
nization by using alum-conjugated OVA, and the CNS-deficient
mice also showed marked attenuation of IgE production (Fig-
ure 1C). By contrast, the CNS2-deficient mice showed enhanced
Th1 cell-mediated IgG2c production. These results suggest
that CNS2 is an important enhancer to control IL-4 expression
required for both basal and antigen-induced IgG1 and IgE
antibody formation.
To determine the impact of CNS2 deficiency on Th2 cell-medi-
ated allergic response, we employed a model of OVA-induced
bronchial asthma. After treating mice by systemic sensitization
to OVA and aerosolized OVA challenge, we induced airway
responsiveness by administering aerosolized acetylcholine.
CNS2- deficient mice had a little higher airway hyperresponsive-
ness and eosinophil attraction into bronchoalveolar lavage (BAL)
fluid compared to control littermate mice, although there was no
statistically significant difference between CNS2-deficient and
control mice (Figure 1D). These data suggest that CNS2 is not
required for development of Th2 cell-mediated asthmatic
disease.
CNS2-Active CD4+ T Cells Have a Phenotype Similar
to Tfh Cells
We have previously generated a transgenic mouse expressing
GFP controlled by the CNS2 enhancer (CNS2-GFP) (Tanaka
et al., 2006). The GFP+ cells in this mouse are CD4+, CD44hi,Immunity 36, 188–200, February 24, 2012 ª2012 Elsevier Inc. 189
Figure 1. Systemic Antibody Response and Th2 Cell Response in CNS2-Deficient Mice
(A) Intracellular staining of IL-4 and GATA3. Naive CD4+ T cells fromWT, HS2-deficient (HS2 KO), and CNS2 KOmice were stimulated for 7 days under Th2 cell-
polarizing conditions and then restimulated with anti-TCRb. Data are representative of two independent experiments with similar results.
(B) ELISA of serum IgG1 in nonimmunizedWT (n = 10), CGRE KO (n = 8), HS2 KO (n = 10), 30 UTR KO (n = 5), HS4 KO (n = 10), CNS2 KO (n = 10), and Il4KO (n = 10)
mice. Each dot represents an individual mouse. Small horizontal lines indicate the mean. ***p < 0.001.
(C) ELISA of total (top) and OVA-specific (bottom) serum IgE, IgG1, and IgG2c in CNS2 KO mice and their control littermates immunized twice with OVA in alum
and then boosted with OVA in PBS, assessed on days 0, 7, 14, and 21 (top) or day 21 (bottom) after immunization.
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NKT cells. MP cells have a cytokine profile distinct from typical
Th2 cells in that they coexpress IL-4 and IFN-g. About 5% of
CD4+ cells in the spleen from unprimed CNS2-GFP mice are
GFP+, but the function of these cells was unknown. Therefore,
we determined the tissue localization of such CNS2-active cells
by examining the frequency of GFP-expressing cells in various
lymphoid tissues from the CNS2-GFP Tg mice. PP contained
the highest percentage of GFP+ cells, and 15%–20% of CD4+
T cellswereGFP+ (Figures 2A and2B). PPare a unique secondary
lymphoid organ continuously exposed to external stimuli such
as the intestinal microflora, and these chronic stimuli lead to
germinal center (GC) formation and generation of Tfh cells and
GC B cells.
Therefore, we focused on the Tfh cell population localized in
PP and studied the role of the CNS2 enhancer in the CXCR5hi
ICOShiPD-1hi Tfh cell population based on GFP expression in
the CNS2-GFP mice. The CXCR5hiPD-1hi population contained
about 45% of GFP+ cells whereas the CXCR5intPD-1int popula-
tion had about 30% of GFP+ cells. By contrast, non-Tfh cells
(CXCR5loPD-1lo) had barely detectable GFP expression (Figures
2C and S2A). Most of the GFP+ cells were CXCR5+PD-1+
CD44hiCD25 (Figure 2D). Moreover, most of the GFP+ cells in
PP were negative for NK1.1 and a-GalCer-loaded CD1d, indi-
cating that they were not NKT cells (Figure S2B). To define the
microanatomical localization of these cells, we looked in tissue
sections of PP from the CNS2-GFP mice and found GFP+ cells
in the B cell follicles (B220) and GC areas (GL7) (Figure 2E). By
contrast, very few GFP+ cells were found in the T cell zones.
The PP-derived GFP+ cells expressed a higher amount of Bcl6
protein than the spleen-derived naive CD4+ T cells (Figure S2C).
To test whether CNS2, in comparison to the other enhancers in
the Il4 locus, is preferentially activated in Tfh cells, we used
Bas-TRECK mice in which the human diphtheria toxin receptor
(DTR) is expressed under the control of 30 UTR and HS4
elements in the Il4 locus. DT treatment of these mice results in
selective depletion of basophils (Sawaguchi et al., 2012; Sira-
cusa et al., 2011), but did not affect the PP Tfh cells (Figure S2D).
Collectively these data indicate that the GFP+ cells have many
characteristic features of Tfh cells in terms of cell surface pheno-
type, Bcl6 expression, and microanatomical localization.
It has been proposed that Tfh cells coexpress IL-4, IL-21, and
IFN-g, all cytokines that play critical roles in immunoglobulin
class switching. Therefore, we examined whether GFP+ cells
in vivo express IL-4 and IL-21 by using two Tg lines, both ex-
pressing human CD2, one controlled by the Il4 locus and the
other by the Il21 locus on a bacterial artificial chromosome
(IL-4-hCD2 BAC Tg and IL-21-hCD2 BAC Tg). In both BAC Tg
mice, there was appropriate expression of IL-4 and IL-21 in
Th2, Th17, and Tfh cells (Figures S2E–S2G). Similar to 4get
mice (Mohrs et al., 2005), IL-4-hCD2 BAC Tg mice probably
report cells competent to secrete IL-4 rather than cells actually
secreting IL-4 protein, as shown by the fact that fewer than
half of the hCD2+ cells are IL-4+. The CNS2-GFP mice were(D) Airway pressure in the mice in (C), given inhaled OVA by the aerosol route afte
(left). Cell content in bronchoalveolar lavage fluid isolated from the challenged m
Total, total cells; Mac, macrophage; Neu, neutrophil; Lym, lymphocyte; Eos, e
experiments with similar results.then crossed with these two Tg lines and IL-4 and IL-21 expres-
sion was studied in PP-derived GFP+CD4+ T cells. About half of
CXCR5hiPD-1hi cells expressed hCD2, whereas few CXCR5lo
PD-1lo cells were hCD2+ (Figures 2F and 2G). About 70% of
the GFP+ cells coexpressed hCD2 in both IL-4-hCD2 BAC Tg
and IL-21-hCD2 BAC Tg mice (Figures 2F and 2G), suggesting
that the majority of GFP+ CNS2-active cells have a cytokine
expression profile similar to Tfh cells.
Gene Expression Pattern of the CNS2-Active Cells
To further characterize GFP+ cells in PP, we carried out a
comprehensive gene expression analysis by microarray. In
comparison with naive CD4+ T cells and spleen-derived GFP+
cells, PP-derived GFP+ cells were quite distinctive from naive
CD4+ T cells, and spleen-derived GFP+ cells seemed to be at
an intermediate stage between PP-derived GFP+ cells and naive
CD4+ T cells (Figure 3A). In comparison with naive CD4+ T cells,
the PP-derived GFP+ cells highly expressed many Tfh cell-
related genes, such as Bcl6, Cxcr5, Pdcd1, Icos, Il4, and Il21.
By contrast, Prdm1 and Ccr7 were found at low amounts in
GFP+ cells. Interestingly, the expression of Gata3, the Th2 cell
master transcriptional factor, and Th2 cell-related cytokines Il5,
Il10, and Il13 was comparable to the levels in naive CD4+
T cells (Figure 3B). These mRNA expression profiles were quite
consistent with qPCR analysis (Figure 3C). In a comparison
between PP-derived GFP+ and GFP cells, Il4mRNA expression
was found to be tightly correlated with the expression of GFP
(Figure 3C). The results also supported the idea that the GFP+
cells correspond to Tfh cells preferentially producing IL-4 and
are quite a distinct population from the well-characterized Th2
cells. These results suggested that CNS2 is the cell type-specific
enhancer to regulate IL-4 expression in Tfh cells.
CNS2 Regulates IL-4 Expression Required for IgG1
and IgE Production
In order to further explore the role of the CNS2 enhancer in Tfh
cells, we examined how CNS2 deletion affected Tfh cell function
and GC B cell development in PP. CNS2-deficient and B6 mice
had a similar proportion of CXCR5hiPD-1hi Tfh cells and Fas+
GL7+ GC B cells (Figures 4A and 4B). However, IgG1-switched
B cells were markedly reduced in CNS2-deficient mice (Fig-
ure 4C), a finding consistent with the lower basal IgG1 antibody
titers (Figure 1B). To identify differences in the pattern of gene
expression in the presence or absence of CNS2, we performed
qPCR analysis on Tfh cells derived from PP of B6 and CNS2-
deficient mice. Tfh cells from the CNS2-deficient mice had
much lower Il4 expression (Figure 4D), suggesting that CNS2 is
a critical Il4 enhancer required for IgG1 class switching in B cells
but does not affect the development of Tfh and GC B cells.
Substantial reduction of Il4 expression was also observed in
HS2-deficient Tfh cells, whereas the deletion of the rest of the
HS site had no effect on Il4 expression (Figure 4E). By contrast,
expression of Tfh cell signature genes such as bcl6, Pdrm1, and
Il21 in CNS2-deficient and HS2-deficient mice was similar to WTr boosting and then treated with various concentrations of acetylcholine (Ach)
ice in (C), assessed by microscopy after Wright-Giemsa staining (right).
osinophil. **p < 0.01, *p < 0.05. Data are representative of two independent
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Figure 2. Distribution of CNS2-Active CD4+ T Cells
(A) The percentage of GFP+ cells among CD4 T cells in spleen, inguinal lymph node (LN), axillary LN, bone marrow, mesenteric LN, Peyer’s patches, intestinal
intraepithelial lymphocytes (IEL), and lamina propria from CNS2-GFP mice.
(B) Quantification of GFP+ cells among CD4+ T cells in spleen, mesenteric LN, inguinal LN, and Peyer’s patches. Data are the mean from four independent
experiments. Error bars are SD.
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are critical for Il4 expression in Tfh cells.
Analysis of our GFP Tg system indicated that the CNS2-active
cells had many of the phenotypic features of Tfh cells. Recently,
we reported an increase of the permissive mark H3K9ac,
H3K14ac, and H3K4me2 in the CNS2 enhancer of Th2 cells,
and Lu et al. (2011) reported an increase of H3K4me2 in Tfh cells.
Therefore, we next wanted to determine the H3 status in the IL-4-
expressing Tfh cells. In GFP+ PP-derived Tfh cells, H3K9ac and
H3K14ac was enhanced at HS2, HS5a, and CNS2 sites (Fig-
ure 4F). We next examined whether the Tfh cell-specific acetyla-
tion events on the Il4 locus of CNS2-deficient Tfh cells are CNS2
dependent. Deletion of CNS2 affects only CNS2 and no other
regulatory region in terms of H3K9ac and H3K14ac, suggesting
that CNS2 is critical for Il4 expression in Tfh cells without
affecting epigenetic modification of the entire Il4 locus (Fig-
ure 4F). These data suggest that CNS2 functions as a critical
enhancer for IL-4 expression in Tfh cells.
We further asked how CNS2 is regulated in Tfh cells. We have
previously demonstrated the contribution of Notch and RBP-J
signaling for CNS2 enhancer activity (Tanaka et al., 2006), and
Yusuf et al. (2010) indicated the importance of the SLAM-SAP
pathway for IL-4 production by Tfh cells. Therefore, we tested
the H3K9ac and H3K14ac status of the CNS2 site in mice with
a T cell-specific deletion of RBP-J (Rbpjf/fCd4cre/) and in
Slamf1/ mice. The deletion of Rbpj did not alter epigenetic
marks on the CNS2 site. However, Slamf1/ cells showed a
slight reduction (Figure S3B). These results suggested marginal
participation of SLAM but not the Notch pathway for CNS2
activity in Tfh cells.
To further define a role of the CNS2 in PP-derived Tfh cells,
CD4+ T cells were isolated from PP of WT, CNS2-deficient,
and CNS2-GFP mice and transferred into CD3ε-deficient mice,
which have low or undetectable titers of T cell-dependent Igs
(IgG, IgA, and IgE) (Figure S4A and data not shown). The adop-
tive transfer of PP-derived CD4+ T cells reconstituted all classes
of Igs including IgE (Figure 5A). The transferred CNS2-GFP
T cells preferentially relocalized in PP within 6 weeks (Fig-
ure S4B). The transfer of T cells derived from WT mice reconsti-
tuted Tfh, GC-B, and IgG1+ B cells in PP (Figure 5B). By
contrast, the transfer of CNS2-deficient T cells failed to reconsti-
tute IgG1+ B cells, even though Tfh and GC B cells were fully re-
constituted (Figure 5B). Consistent with this observation, the
serum IgG1 titers were not fully restored in recipients of the
CNS2-deficient T cells although the IgG2c titers were normal-
ized (Figure 5A). In addition, the transfer of CNS2-deficient
T cells failed to reconstitute the IgE response. Similar recon-
struction results were obtained with transfer of CD4+ T cells
from spleen (Figures S4C–S4F). These data demonstrate that
the CNS2 enhancer plays a role in the production of IL-4 by(C) PP CD4+ T cells from CNS2-GFP mice were stained for CXCR5 and PD-1
CXCR5intPD-1int cells (right bottom), and CXCR5loPD-1lo cells (left bottom). The
(D) PP CD4+ T cells from CNS2-GFP mice were stained for CXCR5, PD-1, CD44
(E) PP section from a CNS2-GFP mouse was stained for GFP (green), CD4 (blue
(F and G) PP CD4+ T cells from CNS2-GFP 3 IL-4-hCD2 BAC double Tg mice (F)
and PD-1 (left top), and hCD2 expression was analyzed in CXCR5hiPD-1hi cell
expression in GFP (red) and GFP+ (blue) CD4+ T cells. Numbers show percenta
The bar graphs show mean and SD (n = 3). Data are representative of three indeTfh cells, which is required for the production of IgG1 and IgE
antibodies.
CNS2-Active Tfh Cells Develop from Naive CD4 T Cells
We have previously demonstrated that GFP+ cells were found
among CD4 single-positive T cells in the thymus of the CNS2-
GFP mice, suggesting that CNS2-active Tfh cells develop
stochastically during the thymic differentiation process. Another
possibility is that, like other Th cell subsets, naive T cells would
be the precursors of CNS2-active Tfh cells and that TCR activa-
tion might instruct the differentiation process. To examine this
issue, the CNS2-GFP Tgmice provided us quite a useful window
to study the ontogeny of CNS2-active Tfh cells. As shown in our
previous report (Tanaka et al., 2006), GFP+ cells did not appear
fromGFPCD4 T cells under Th2 cell-skewing conditions, which
highly induced IL-4 and ICOS but not CXCR5 andPD-1, suggest-
ing that CNS2 is not activated in Th2 cells (Figure S5). We then
transferred unfractionated CD4 T cells or GFP CD4 T cells
from spleen into Cd3e-deficient mice and found that GFP+ Tfh
cells were reconstituted in both transfer groups (Figure 6A). In
PP reconstituted with GFP cells, about 50% of Tfh cells
became GFP+ (Figure 6B). These data indicate that CNS2-active
Tfh cells can develop from naive T cells, in which the CNS2
enhancer is normally silent and suggest the possibility that this
development from the naive CD4+ T cells results from stimulation
by the intestinal microflora, although we could not definitively
exclude the possibility that CNS2-active cells arise through a
homeostatic mechanism.
Therefore, we tested whether development of CNS2-active
Tfh cells is controlled by antigenic stimuli. GFPCD62Lhi naive
CD4+ T cells were sorted from double CNS2-GFP and OT-II Tg
mice (Figure 6C) and then transferred into Ly5.1 congenic mice
followed by systemic immunization with OVA and alum. This
systemic immunization caused the appearance of GFP+ cells
among donor-derived CD4+ T cells, and the percentage of
GFP+ cells markedly increased from day 3 to day 5. GFP+ cells
were found in several lymphoid tissues including PP, mesenteric
LN, and spleen (Figures 6D and 6E). The majority of GFP+ cells
had a CXCR5hiPD-1hi Tfh cell phenotype, and more than half of
the Tfh cells were GFP+ (Figure 6F). These data indicate that
antigen stimulation instructed the development of CNS2-active
Tfh cells from naive CD4+ T cells.
DISCUSSION
Analyses ofmicewith a targeted deletion or a transgenic reporter
construct demonstrated a nonredundant function of the
conserved cis-acting element CNS2, which accounts for Tfh
cell-specific regulation of the Il4 gene. Deletion of CNS2 resulted
in a profound reduction in antigen-specific IgG1 and IgE(left), and GFP expression was analyzed in CXCR5hiPD-1hi cells (right top),
bar graph shows mean and SD of the percent GFP+ cells (n = 4).
, and CD25.
), and GL-7 (red).
or CNS2-GFP3 IL-21-hCD2 BAC double Tg mice (G) were stained for CXCR5
s (right top) and CXCR5loPD-1lo cells (right middle). Histograms show hCD2
ges of hCD2+ cells in GFP cells (red) and GFP+ cells (blue).
pendent experiments.
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Figure 3. Gene Expression of CNS2-Active CD4+ T Cells in PP
(A and B) Microarray analysis of gene expression. Spleen naive CD4+ T cells (CD4+, CD62Lhi), spleen GFP+ cells (CD4+, GFP+), and PP GFP+ cells (CD4+, GFP+)
were sorted and total mRNA was isolated.
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mally results in Th2 cell humoral immunity, and this defect was
mainly due to loss of IL-4 expression by Tfh cells. The CNS2-
GFP mouse model allowed us to visualize Tfh cells capable of
expressing the Il4 gene. GFP+ T cells exhibited several Tfh cell
markers and a characteristic localization, being preferentially
found in the B cell follicles and GC areas. In an in vivo system,
GFP+ Tfh cells were found to develop from naive T cells after
OVA sensitization. Therefore we conclude that CNS2 is an active
and specific enhancer for IL-4-producing Tfh cells and is crucial
for IgG1 and IgE humoral responses.
By using a series of mutant mice bearing deletions of each HS
site located in the Il4-Il13 locus, this study indicates that CNS2
accounts for basal serum IgG1 titers and for IL-4 expression in
Tfh cells. PP-derived Tfh cells can be divided into at least two
populations based on IL-4 production, and a similar heteroge-
neous expression of IL-21 by Tfh cells was also observed.
CNS2-controlled GFP expression overlapped well with IL-4
production, indicating that CNS2 is responsible for Il4 expres-
sion in Tfh cells. Our data are consistent with a previous report
indicating the importance of IL-4 production in the PP for the
generation of basal IgG1 titers (Butcher et al., 1982).
Unlike Tfh cells, Th2 cells derived ex vivo were less dependent
on CNS2 for Il4 expression, consistent with previously reported
observations with in vitro differentiated Th2 cells frommice lack-
ing CNS2 (Tanaka et al., 2011). IL-4 signaling induces nuclear
translocation of STAT6, which is a direct transactivator of both
Il4andGata3.GATA3, in turn, binds to several cis-regulatory sites
in the Il4 locus, andCNS2 is known to be a target of GATA3 in Th2
cells (Agarwal et al., 2000; Takemoto et al., 2000, 2002; Tanaka
et al., 2011). However, CNS2-active Tfh cells express quite
a low amount of GATA3, comparable to that of naive T cells.
We previously demonstrated that HS2 is the most crucial
enhancer element as a target of GATA3 in Th2 cells (Tanaka
et al., 2011). Interestingly, the targeted deletion of HS2 also
caused substantial reduction of Il4 expression in Tfh cells;
however, a highly selective deletion of the GATA3 binding site
failed to reduce Il4 expression (data not shown), suggesting the
involvement of an unknown mechanism in GFP+ Tfh cells. More-
over, Tfh cells do not express Il5 and Il13, geneswhose transcrip-
tion is largely dependent on GATA3 by its direct binding to their
promoter, CGRE (Kishikawa et al., 2001; Yamashita et al., 2002;
Zhang et al., 1998). These results are consistent with the idea
that the underlying IL-4 production system in Tfh cells is different
from that in conventional Th2 cells, and it seems to beGATA3and
STAT6 independent (Yusuf et al., 2010). These data are also
consistent with the unexpected results obtained in our previous
report on CNS2-GFP Tgmice (Tanaka et al., 2006). CNS2 activity
was detected in unique T cell subsets, such as MP, NK T cells,(A) Left: Scatter plot of spleen naive CD4+ T cell versus PP GFP+CD4+ T cell (to
expression microarray data is shown (log2 scale). Green lines indicate 3-fold expre
upregulated (top) and downregulated (bottom) genes in PP GFP+ cells compared
(B) The expression of genes encoding molecules involved in Th cell differentiation
naive CD4+ T cells.
(C) Quantitative RT-PCR analysis of the expression of Tfh and Th2 cell-related gen
PP GFP cells (CD4+, GFP), and PP GFP+ cells (CD4+, GFP+) were sorted and to
under Th1 and Th2 cell conditions, respectively. Data were normalized to expres
Data are representative of three (A) or two (C) independent experiments or are frand T-CD4 cells (Sofi et al., 2011; Tanaka et al., 2006). IL-4
expression in MP cells was largely independent of STAT6, and
littleGATA3proteinwasdetected inCNS2-activeMPcells. These
results suggest that CNS2 is commonly used in a GATA3-inde-
pendent manner for IL-4 expression in both Tfh and NKT cells.
GFP+ T cells in CNS2-GFP mice satisfied all criteria defined for
Tfh cells, with increased expression of CXCR5, ICOS, PD-1,
CD200, BTLA, OX40, and SLAM-associated protein (SAP), the
transcription factor Bcl6 and BATF, downregulation of CCR7,
CD127, and Blimp1, and the coexpression of cytokines, IL-4,
IL-21, and IFN-g (strongly suggesting that CNS2-active T cells
are part of the Tfh cell lineage). Our data are consistent with
previous suggestions that the initial commitment of naive CD4+
T cells to the Tfh cell lineage is dependent upon TCR activation
(Fazilleau et al., 2009), because a substantial number of naive
CD4+ T cells differentiated into CNS2-active Tfh cells after antigen
stimulation.CNS2 is silent in naive T cells, but TCRactivation leads
to activation of this enhancer, particularly in the Tfh cell lineage.
However, CNS2was not activated during ex vivo Th2 cell differen-
tiation, when cells were activated by TCR crosslinking with anti-
body (Tanaka et al., 2006). TCR activation for Tfh cell development
appears to be dependent on T cell-DC interactions during the
priming phase (Baumjohann et al., 2011; Kerfoot et al., 2011; Ki-
tano et al., 2011), andB cell interactions are then required to stabi-
lize Bcl-6 expression. DCs can also substitute for this B cell func-
tion in antigen presentation when mice receive repeated peptide
immunization (Deenick et al., 2010). These findings suggest that
particular costimulation conditions may be required for the induc-
tion of the enhancer activity controlled by the CNS2 element.
Therefore, our data have revealed a unique role of CNS2 during
the induction phase of Il4 gene expression in the Tfh cell lineage.
A remaining question is which signal pathway regulates Il4
transcription in Tfh cells instead of the IL-4-STAT6-GATA3
pathway. We have previously demonstrated that Notch and
RBP-J signaling regulates CNS2 enhancer activity in NKT and
MP CD4+ T cells. Conditional T cell-specific deletion of RBP-J
resulted in reduced IgG1 and IgE production and the complete
attenuation of the appearance of GFP+ cells (Tanaka et al.,
2006). Therefore, Notch-RBP-J signaling is a candidate for the
regulation of Il4 expression in Tfh cells through the CNS2
enhancer. Another possibility is the signal from the signaling
lymphocytic activation molecule-SLAM-associated protein
(SLAM-SAP) pathway. SLAM is required for IL-4 production
but not for IL-21 production by Tfh cells (Yusuf et al., 2010).
SAP-deficient Tfh cells are defective in IL-4 and IL-21 produc-
tion, even though the SAP-deficient T cells are able to secrete
IL-4 under Th2 cell-polarizing conditions (Wu et al., 2001; Yusuf
et al., 2010). In addition, the SLAM-SAP pathway controls
the development of thymocyte-selected IL-4-producing CD4+p) or spleen naive CD4+ T cell versus spleen GFP+CD4+ T cell (bottom) gene
ssion changes. Right: Heat-map analysis of gene expression. More than 5-fold
to spleen naive CD4+ T cells are shown.
and function in PP GFP+ cells. Results are presented relative to those of spleen
es. Spleen naive CD4+ T cells (CD4+, CD62Lhi), spleen GFP+ cells (CD4+, GFP+),
tal RNA was isolated. Th1 and Th2 cells were prepared by culturing for 7 days
sion of Actb.
om three independent experiments (B). Error bars are SD.
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Figure 4. CNS2 Is Required for IL-4 Expression in PP Tfh Cells but Not for Tfh Cell Development
(A–C) Representative flow cytometric plots (left) and quantification (right bar graphs) of Tfh cells identified as CD4+CXCR5hiPD-1hi (A), GC B cells identified as
B220+Fas+GL-7+ (B), and IgG1+ B cells identified as B220+IgG1+ (C) in PP from WT and CNS2-deficient (CNS-2) mice.
(D) Quantitative RT-PCR analysis of the expression of Tfh and Th2 cell-related genes. PP CD4+CXCR5 or PP CD4+CXCR5+ cells from WT and CNS2 KO mice
were sorted and total mRNA was isolated. Data were normalized to expression of Actb.
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Figure 5. CNS2 Is Essential for CD4+ T Cell-
Mediated IgG1 Class Switching
(A and B) PP CD4+ T cells from WT or CNS2-
deficient (CNS2 KO) mice were transferred into
Cd3e KO mice. After 6 weeks, the mice were
analyzed.
(A) Serum IgG1, IgG2c, and IgE concentrations in
Cd3e KOmice transferred with WT (n = 3) or CNS2
KO (n = 3) CD4+ T cells were measured by ELISA.
(B) Flow cytometric plots of Tfh cells (left), GC B
cells (middle), and IgG1+ B cells (right) in PPs
from Cd3e KO mice transferred with WT or CNS2-
deficient CD4+ T cells. Numbers show the
percentage of cells in the gated areas. ***p < 0.001.
Data are representative of two independent
experiments. Error bars are SD.
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regulates Il4 transcription in NKT cells and the ‘‘T-CD4’’ cells (Li
et al., 2007; Sofi et al., 2011; Tanaka et al., 2006). NKT cells and
T-CD4 T cells derived from SAP-deficient mice showed fewer IL-
4+ cells in the periphery (Li et al., 2007; Ma et al., 2007; Veillette
et al., 2007). These results suggest the importance of SLAM-SAP
signaling in CNS2-mediated Il4 transcription in NKT cells and Tfh
cells. Our ChIP data indicate partial involvement of the SLAM
pathway, but the effect is marginal compared to IL-4 expression
in SAP-deficient mice. Therefore, further investigation of the
Notch-RBP-J or SLAM-SAP pathway for IL-4 expression in Tfh
cells is warranted.
In summary, our data have revealed a critical role for the distal
Il4 enhancer CNS2 in Tfh cell function. Consequently, CNS2 is
dispensable for Th2 cell function but plays an important role in
Il4-mediated humoral responses mainly regulated by Tfh cells.(E) Quantitative RT-PCR analysis of Il4 gene expression. PP CD4+CXCR5 or PP CD4+CXCR5+ cells fromWT,
KO mice were sorted and total mRNA was isolated. Data were normalized to expression of Actb.
(F) ChIP analysis of chromatin from naive CD4+ T cells and PP-derived GFP+ cells in CNS2-GFP mice (top) o
(bottom). Chromatin was immunoprecipitated with antibody to H3K9ac and H3K14ac, then analyzed by
chromatin components or an equivalent mass of input DNA (purified from chromatin fractions before immuno
2CT(IP) to 2CT(input), where IP is immunoprecipitated chromatin and CT indicates the cycling threshold.
Data are representative of three (A, B, C) or two (D, E) independent experiments. Error bars are SD.
Immunity 36, 188–200,Moreover, our ability to track CNS activity
has provided insight into the ontogeny of
Tfh cells. Our data imply that Tfh cells and
Th2 cells utilize distinct but, in some
aspects, overlapping molecular mecha-
nisms to secrete IL-4 during allergic
responses. CNS2 is a unique enhancer
element responsible for Tfh cell-specific
expression of the Il4 gene.
EXPERIMENTAL PROCEDURES
Mice
CNS2-GFP mice harbored a GFP reporter gene
regulated by the 50 enhancer (863 to 5448;
starting codon is defined as sequence number
0), the Il4 promoter (64 to 827), and the distal
30 fragment (+11552 to +15635) containing whole
CNS2 region but not HS5a. CNS2-deficient micewere made by deleting the whole CNS2 region and the last half of HS5a
(+11305 to +12964). Deletion mouse of CNS2, HS2, CGRE, HS4, and 30 UTR
CNS2-GFP transgenic mouse, Rbpjf/f, and slam/ mice were described in
previous reports (Davidson et al., 2004; Tanaka et al., 2006, 2011). Il4-deficient
mice were provided by M. Kopf (Kopf et al., 1993). All mice used in this study
were maintained under specific-pathogen-free conditions, and animal care
was in accordance with guidelines of the RIKEN Yokohama Institute or Tokyo
University of Science.
Antibodies
ELISA analysis was carried out with the following antibodies: anti-IgM (II/41
and R6-60.2 biotin; BD Biosciences, San Diego, CA), anti-IgG1 (1070-01;
Southern Biotech, Birmingham, AL, and A90-105P; Bethyl, Montgomery,
TX), anti-IgG2b (A90-109A and A90-109P; Bethyl), anti-IgG2c (A90-136A;
Bethyl and 1079-05; Southern Biotech), anti-IgA (A90-103A and A90-103P;
Bethyl), and anti-IgE (1130-01; Southern Biotech and R35-118 biotin; BD
Biosciences). An OVA-specific IgE ELISA was carried out with the ELISA kit
system from Dai-Nippon Seiyaku Ltd (Osaka Japan). Anti-CD4 (RM4-5),CGREKO, HS2 KO, 30 UTR KO, HS4KO, andCNS2
r PP CD4+CXCR5+ cells in WT and CNS2 KO mice
real-time PCR of DNA from immunoprecipitated
precipitation). Results are presented as the ratio of
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Figure 6. CNS2-Active CD4+ T Cells Are Generated in the Periphery
(A) Total (left top) or GFP (left bottom) splenic CD4+ T cells from CNS2-GFP mice were transferred into Cd3e-deficient mice and the percentage of GFP+ cells
among donor CD4+ T cells from spleen (middle) and PP (right) was analyzed 4 weeks after adoptive transfer.
(B) PP donor CD4+ T cells were stained for CXCR5 and PD-1 (left), and GFP expression was analyzed in CXCR5hiPD-1hi cells (right).
(C–F) GFP splenic naive CD4+ T cells fromOT-II CNS2-GFPmice were transferred into Ly5.1 congenic mice and subsequently immunized with OVA in alum. The
mice were analyzed 3, 5, and 7 days after immunization.
(C) GFP naive CD4+ T cells (CD4+CD62Lhi) were sorted and purity was analyzed by flow cytometry.
(D) Flow cytometric plots of donor CD4+ T cells in the spleen 3, 5 (top), and 7 (bottom right, OVA(+)) days after immunization or donor CD4+ T cells in the spleen
from nonimmunized recipient (bottom left, OVA(-)). The percentage of GFP+ cells is shown.
(E) Quantification of GFP+ cells in indicated tissues (n = 3).
(F) Splenic donor CD4+ T cells (day 7) were stained for CXCR5 and PD-1 (left), andGFP expression was analyzed in CXCR5hiPD-1hi cells (middle). Quantification of
GFP+ cells in CXCR5hiPD-1hi cells in the indicated tissues (n = 3) (right).
Data are representative of two independent experiments. Error bars are SD.
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Distinct Il4 Gene Regulation in Th2 and Tfh CellsPD-1 (RMP1-30), ICOS (15F9), human CD2 (RPA-2), CD62L (MEL-14), B220
(RA3-6B2), NK1.1 (PK136), CD3ε (145-2C11), CD45.2 (104) (Biolegend, San
Diego, CA), CXCR5 (2G8), IgG1 (A85-1), IL-4 (11B11), IL-17 (TC11-18H10),
GATA3 (L50-823), Bcl6 (K112-91), CD44 (IM7), c-kit (2B8), FceRI (MAR-1),
CD49b (DX5) (BD Biosciences), and CD25 (PC61) (eBioscience, San Diego,
CA) were used for FACS analysis.
Cell Preparation and Helper T Cell Induction
CD4+ T cells were isolated from mouse spleen with the IMag magnetic bead
system (BD Bioscience), and naive CD4+ T cells (CD62Lhi) were isolated by
cell sorting with a FACSAria II (BD Biosciences). T cells (1 3 106 cells/ml)
were stimulated with plate-bound TCR antibody (H57-597) and CD28 antibody
(PV-1) (R. Abe, Research Institute for Biological Sciences, Tokyo University of
Science). For induction of Th2 cells, cells were stimulated for 7 days in the
presence of mIL-4 (Peprotech, London, UK) and IFN-g mAb (R4 6A2, BD
Bioscience). For Th17 cell induction, cells were stimulated for 7 days in cultures
containing human rTGF-b (R&D Systems, Minneapolis, MN) (10 ng/ml) and
mrIL-6 (R&D Systems) (4 ng/ml) in the presence of IL-4 mAb and IFN-gmAb.
Intracellular Cytokine Staining
CD4+ T cells were restimulated with TCRbmAb for 6 hr in the presence of 2 mM
monensin (Sigma, St. Louis, MO). The cells were fixed with 4% paraformalde-
hyde and permeabilized with 0.5% Triton X-100. After blocking with 3%
BSA-PBS, cells were stained with the following mAb: IL-4 PE (11B11; BD
Biosciences), IL-17 PE (TC11-18H10; BD Biosciences), GATA3 Alexa 647
(L50-823; BD Biosciences), and Bcl6 PE (K112-91; BD Biosciences). Flow
cytometric analysis was performed on a FACS caliber and data were analyzed
with FlowJo software (Tree Star, Inc., Ashland, OR).
Microarray Analysis and Quantitative RT-PCR
Total RNA was isolated with RNeasy micro kit (QIAGEN, Valencia, CA). Micro-
array analyses were performed with an Affymetrix microarray chip (Mouse
Genome 430 2.0 array, Affymetrix, Santa Clara., CA) and normalized with
Genespring software (Silicon Genetics). Quantitative real-time PCR was
carried out with a 7500 Fast real-time PCR system (AppliedBiosystems, Foster
City, CA). Primers used were as follows: Bcl6: 50-cctgtgaaatctgtggcactcg-30
(forward), 50-cgcagttggcttttgtgacg-30 (reverse); Prdm1: 50-acatagtgaacgacca
cccctg-30 (forward), 50-cttaccacgccaataacctctttg-30 (reverse); Il4: 50-cttatcgat
gaatccaggcatcg-30 (forward), 50-catcggcattttgaacgaggtca-30 (reverse); Ifng:
50-ggatgcattcatgagtattgc-30 (forward), 50-ccttttccgcttcctgagg-30 (reverse);
Il13: 50-ggcccccactacggtctcca-30 (forward), 50-gaaggggccgtggcgaaaca-30
(reverse); Il21: 50-gctccacaagatgtaaaggggc-30 (forward), 50-ccacgaggtcaatga
tgaatgtc-30 (reverse); Gata3: 50-agaaccggccccttatcaa-30 (forward), 50-agttcg
cgcaggatgtcc-30 (reverse); and actb: 50-actattggcaacgagcggttc-30 (forward),
50-ggatgccacaggattccatac-30 (reverse).
Antibody Formation and AHR
Mice were immunized by intraperitoneal injection with 100 mg OVA (grade V,
Sigma Aldrich) emulsified in alum (PIERCE, Rockford, IL) on day 1 and day
10. Boosting was performed with OVA in PBS on day 23. Sera were obtained
at day 0, day 7, and day 14 after initial immunization, and total and OVA-
specific IgG1, IgG2c, and IgE were measured by ELISA. The OVA-immunized
mice were challenged with OVA by inhalation after boosting at day 23, and
acetylcholine-dependent AHRwas measured. Cellular content in the BAL fluid
was assessed by Wright-Giemsa staining and cell counting.
T Cell Transfer
In the experiment in Figure 1, mice were immunized with OVA (100 mg) (Sigma)
and aluminum hydroxide gel (alum) (2.25 mg) (Sigma) intraperitoneally twice
and boosted with OVA in PBS. In the experiment in Figure 6C, 2 3 105 OT-II
T cells were transferred into Ly5.1 congenic mice intravenously and immu-
nized with OVA (100 mg) in alum (2.25 mg) intraperitoneally on the next day
of transfer. In the experiment of T cell transfer into CD3ε-deficient mice, 2 3
105 CD4+ T cells were transferred intravenously.
Immunofluorescence Staining of Sections
PP were fixed with 4% paraformaldehyde and transferred to a 30% sucrose
solution. PP were then frozen in OCT freezing medium (Sakura Finetek Japan,Tokyo, Japan). PP sections were stained with anti-GFP Alexa 488 (Invitrogen),
anti-CD4 biotin (L3T4; eBioscience) which was detected by streptavidin Alexa
546, and anti-GL7 Alexa 647 (BD Biosciences). Images were acquired on an
epifluorescence microscope BZ-9000 (Keyence, Osaka, Japan).
Statistical Analysis
All data are presented as mean and SD and statistical analysis was performed
with the Student’s t test. Differences were recognized as significant with a
p value of <0.05.
Chromatin Immunoprecipitation Assay
The nuclear fraction was extracted as chromatin from sonicated cells. After
preclearance with a mixture of protein A and protein G-sepharose (Amersham,
Piscataway, NJ), the chromatin fractions were incubated with the specified
antibody. The ‘‘input’’ sample was defined based on the DNA extract prepared
from untreated chromatin. DNA was extracted from the immunoprecipitated
chromatin, and the concentration was quantified with a PicoGreen fluores-
cence assay kit (Molecular Probes, Eugene, OR). Equivalent masses of IP
and input DNA were compared by real-time PCR. Data are presented as
the ratio of IP to input CT values. The primers are described in previous report
(Tanaka et al., 2011).
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